Suggested reading

ANSIRH’s office has a library with almost every book published on the topic of abortion, as well as a digital library for journal publications related to abortion. As a way of trying to share it with you, we'll periodically compile lists of books and articles we think will interest you. The most current list is detailed below; previous lists are archived as downloadable pdfs and include:

Articles and books on abortion that were published in the peer-reviewed literature in 2008 (revised January 2009)
Resources on the history of abortion, to mark the 36th anniversary of Roe v. Wade (revised December, 2008)

Reading list on medication abortion

Acceptability

Clark S, Ellertson C, Winikoff B. “Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion.” J Am Med Womens Assoc 2000;55(3 Suppl):177-82.
Joffe C. “Reactions to medical abortion among providers of surgical abortion: an early snapshot.” Fam Plann Perspect 1999;31(1):35-8.
Winikoff B, Ellertson C, Elul B, Sivin I. “Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group.” Arch Fam Med 1998;7(4):360-6.
Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Xiao B, Gu S, et al. “Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.” American Journal of Obstet Gynecol 1997;176(2):431-7.

Reducing medical barriers

Berer M. “Medical abortion: issues of choice and acceptability.” Reproductive Health Matters 2005;13(26):25-34.
Clark WH, Gold M, Grossman D, Winikoff B. “Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.” Contraception 2007;75(4):245-50.
Ellertson, C., Elul, B., Winikoff, B. “Taking the medical out of medical abortion: Can women use mifepristone-misoprostol without medical supervision?” Reproductive Health Matters 1997;(9)149-161.
Elul B, Hajri S, Ngoc NN, Ellertson C, Slama CB, Pearlman E, et al. “Can women in less-developed countries use a simplified medical abortion regimen?” Lancet 2001;357(9266):1402-5.
Gomperts RJ, Jelinska K, Davies S, Gemzell-Danielsson K, Kleiverda G. “Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.” BJOG 2008;115(9):1171-5; discussion 1175-8.
Grossman D, Ellertson C, Grimes DA, Walker D. “Routine follow-up visits after first-trimester induced abortion.” Obstet Gynecol 2004;103(4):738-45.
Harper C, Ellertson C, Winikoff B. “Could American women use mifepristone-misoprostol pills safely with less medical supervision?” Contraception 2002;65(2):133-42.

Provision by advanced practice clinicians

Berer M. “Provision of abortion by mid-level providers: international policy, practice and perspectives.” Bull World Health Organ 2009;87(1):58-63.
Hwang AC, Koyama A, Taylor D, Henderson JT, Miller S. “Advanced practice clinicians' interest in providing medical abortion: results of a California survey.” Perspect Sex Reprod Health 2005;37(2):92-7.
Yarnall J, Swica Y, Winikoff B. “Non-physician clinicians can safely provide first trimester medical abortion.” Reprod Health Matters 2009;17(33):61-9.

Counseling

Breitbart V. “Counseling for medical abortion.” Am J Obstet Gynecol 2000;183(2 Suppl):S26-33.

Integration of medication abortion into medical practices

Afable-Munsuz A, Gould H, Stewart F, Phillips KA, Van Bebber SL, Moore C. “Provider practice models for and costs of delivering medication abortion - evidence from 11 US abortion care settings.” Contraception 2007;75(1):45-51.
Joffe C, Weitz TA. “Normalizing the exceptional: incorporating the "abortion pill" into mainstream medicine.” Social Science & Medicine 2003;56(June):2353-2366.
Kawonga M, Blanchard K, Cooper D, Cullingworth L, Dickson K, Harrison T, et al. “Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa.” J Fam Plann Reprod Health Care 2008;34(3):159-64.
Leeman L, Asaria S, Espey E, Ogburn J, Gopman S, Barnett S. “Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?” Contraception 2007;76(2):96-100.
Shochet T, Trussell J. “Determinants of demand: method selection and provider preference among US women seeking abortion services.” Contraception 2008;77(6):397-404.
World Health Organization. Frequently Asked Clinical Questions about Medical Abortion. Conclusions of an International Consensus Conference on Medical Abortion in Early First Trimester. Bellagio, Italy; 2006.

Medication vs. surgical abortion

Creinin MD. “Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion.” Contraception 2000;62(3):117-24.
Lohr PA, Hayes JL, Gemzell-Danielsson K. “Surgical versus medical methods for second trimester induced abortion.” Cochrane Database Syst Rev 2008(1):CD006714.
Say L, Kulier R, Gulmezoglu M, Campana A. “Medical versus surgical methods for first trimester termination of pregnancy.” Cochrane Database Syst Rev 2005(1):CD003037.
Wiegerinck MM, Jones HE, O'Connell K, Lichtenberg ES, Paul M, Westhoff CL. “Medical abortion practices: a survey of National Abortion Federation members in the United States.” Contraception 2008;78(6):486-91.

Cost effectiveness

Creinin MD, Shore E, Balasubramanian S, Harwood B. “The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.” Contraception 2005;71(1):26-30.
Hu D, Grossman D, Levin C, Blanchard K, Goldie SJ. “Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.” BJOG 2009;116(6):768-79.
Murthy A, Creinin MD. “Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.” Expert Opin Pharmacother 2003;4(4):503-13.
Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart F. “Patient costs for medication abortion: results from a study of five clinical practices.” Women's Health Issues 2006;16(1):4-13.

Complications of medication abortion

Hausknecht R. “Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States.” Contraception 2003;67(6):463-5.
Fjerstad M, Trussell J, Sivin I, Lichtenberg ES, Cullins V. “Rates of serious infection after changes in regimens for medical abortion.” N Engl J Med 2009;361(2):145-51.
Kruse B, Poppema S, Creinin MD, Paul M. “Management of side effects and complications in medical abortion.” Am J Obstet Gynecol 2000;183(2 Suppl):S65-75.
Shannon C, Brothers LP, Philip NM, Winikoff B. “Infection after medical abortion: a review of the literature.” Contraception 2004;70(3):183-90.
Virk J, Zhang J, Olsen J. “Medical abortion and the risk of subsequent adverse pregnancy outcomes.” N Engl J Med 2007;357(7):648-53.

Efficacy of medication abortion

Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. “Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.” BJOG2002;109(11):1281-9.
Hedley A, Trussell J, Turner AN, Coyaji K, Ngoc NT, Winikoff B, et al. “Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion.” Contraception 2004;69(2):157-63.

If you have other publications to recommend, please email us.